| Popis: |
BWOLF (DH 180/185) flowlines, in the deepwater Gulf of Mexico, were being treated continuously with LDHI to manage hydrate risk. Application of the Anti-Agglomerant (AA) was being utilized to treat the asset under the initial conditions, including water cuts up to 20%, for potential unplanned shut ins. Due to a well zone change, water cut dropped from 20% to Rocking cell testing was conducted to determine the optimal chemical treating doses using AA alone, as well as AA + MeOH as options. However, the rocking cell equipment limitation for water cuts is ~10%, below which results have previously not been trusted. Extrapolation for estimated dosages were needed for the lower water cuts observed in the field. Autoclave tests were done at higher water cuts (30 and 50%) to also provide data for curve fitting to confirm whether the increase need for LDHI at lower water cuts was indeed exponential in nature. Field monitoring of flowline pressures was conducted to determine treatment effectiveness. Additionally, field monitoring of water cut over time was also observed and related back to how the chemical treatment behaved in relation. After the well zone change, application of the AA alone was not enough to effectively address the hydrate risk and resulted in gradual build up of hydrate within the system. Periodic MeOH pills were applied to reduce delta pressure, but care was necessary to avoid reaching MeOH limitations within the crude. Additionally, this method did not effectively remove hydrate formation in the flowline. Less frequently, but when necessary, dead oiling was utilized to remove the build up quite effectively. This was not ideal due to down time and deferred production. It's felt that Webber et al. correctly described the significant increase of AA dosing requirements at very low water cuts ( |
